Duloxetine: clinical pharmacokinetics and drug interactions.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2011 AND VI 50 AND IP 5
Results: 6
1
2
Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 5, p. 331, doi. 10.2165/11539680-000000000-00000
- Publication type:
- Article
3
Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 5, p. 319, doi. 10.2165/11584550-000000000-00000
- Publication type:
- Article
4
Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 5, p. 307, doi. 10.2165/11539250-000000000-00000
- Publication type:
- Article
5
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 5, p. 295, doi. 10.2165/11586040-000000000-00000
- Publication type:
- Article
6
Duloxetine Clinical Pharmacokinetics and Drug Interactions.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 5, p. 281, doi. 10.2165/11539240-000000000-00000
- Publication type:
- Article